Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...
Yahoo Finance provides transcripts for the latest Vertex, Inc. (VERX) earnings call and access historical call transcripts to help inform your investment decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results